 low-dos cyclopenthiazid treatment hypertens one-year community-bas studi placebo period patient diastol blood pressur mmhg microgram low dose microgram cyclopenthiazid standard dose period year blood pressur patient home observ two-weekli interv placebo run-in period week week week serum potassium urat glucos glycosyl haemoglobin total hdl cholesterol apolipoprotein end placebo period week activ treatment patient inadequ antihypertens respons dose dose patient microgram advers effect patient systol diastol blood pressur pretreat valu treatment group year period decreas blood pressur differ patient microgram potassium supplement maximum decreas serum potassium mmol/l microgram mmol/l microgram week treatment patient differ dose time signific increas serum urat week